Lung Imaging

News and new technology innovations concerning how imaging technology for the lungs. This includes computed tomography (CT), X-ray and ultrasound imaging of the lungs to diagnose and monitor treatment for lung cancer, COPD, pulmonary embolism (PE), pneumonia, tuberculosis and COVID-19 can be found on this channel.

Lung autopsy and plasma samples from people who died of COVID-19 have provided a clearer picture of how the SARS-CoV-2 virus spreads and damages lung tissue. Scientists at the National Institutes of Health and their collaborators say the information, published in Science Translational Medicine, could help predict severe and prolonged COVID-19 cases, particularly among high-risk people, and inform effective treatments.

News | Coronavirus (COVID-19)

Lung Autopsies of COVID-19 Patients Reveal Treatment Clues

November 22, 2021 — Lung autopsy and plasma samples from people who died of COVID-19 have provided a clearer picture of ...

November 22, 2021

Lung cancer screening is recommended only for those who are at high risk for the disease — adults ages 50–80 who smoke at least 20 packs a year—but even among members of that high-risk group, screening rates remain low, ranging from 5% to 20% of those eligible for the screening CT scan.

News | Lung Imaging

Lung Cancer Screening Rates Increase With Access to Medicare

November 19, 2021 — Lung cancer screening is recommended only for those who are at high risk for the disease — adults ...

November 19, 2021

Reveal 35C is the world’s first single exposure portable dual-energy X-ray detector.

News | X-Ray

KA Imaging’s Reveal 35C Shown to Find More Pneumonia Cases Than Traditional X-ray

November 19, 2021 — “Data drive decisions and with the latest trial data, we are positioned for growth,” said Amol ...

November 19, 2021

The CE-IVD marked Aiforia Clinical AI Model for Lung Cancer; PD-L1 is intended for use by pathologists in supporting them to detect and calculate the levels of the biomarker in non-small cell lung cancer cases.

News | Artificial Intelligence

Aiforia Achieves CE-IVD Mark for Clinical PD-L1 AI Model in Lung Cancer Diagnostics

November 18, 2021 — Worldwide the most common cause of cancer mortality in 2020 was lung cancer, with an estimated 1.80 ...

November 18, 2021

VIDA Diagnostics Inc. (VIDA) is further removing friction in respiratory clinical trials with the introduction of a new artificial intelligence (AI)-powered portal. The cloud-based VIDA Intelligence Portal (VIP) streamlines challenges often associated with imaging in trials such as site onboarding, staff training, image data management, and data quality.

News | Artificial Intelligence

VIDA Streamlines Respiratory Clinical Trials With AI

November 18, 2021 — VIDA Diagnostics Inc. (VIDA) is further removing friction in respiratory clinical trials with the ...

November 18, 2021

58-Year-Old Woman With Right Lower Lobe Nodule: (a) Present lung cancer screening CT and (b) lung cancer screening CT performed 2 years prior. Nodule described as growing pure ground-glass nodule (associated with cystic lesion), measuring 15 mm in mean diameter. Nodule categorized Lung-RADS 3 by clinical report, though Lung-RADS 2 by strict application of size criteria. Subsequent wedge resection demonstrated lepidic-predominant adenocarcinoma.

News | Lung Imaging

Cancer Risk in Nodules Detected at Follow-up Lung Cancer Screening CT

November 10, 2021 — According to an article in ARRS’ American Journal of Roentgenology (AJR), Lung-RADS — as applied by ...

November 10, 2021

Scientists from UCL and the European Synchrotron Research Facility (ESRF) used a new revolutionary imaging technology called Hierarchical Phase-Contrast Tomography (HiP-CT), to scan donated human organs, including lungs from a Covid-19 donor.

News | Coronavirus (COVID-19)

Brightest Ever X-ray Shows Lung Vessels Altered by COVID-19

November 5, 2021 — The damage caused by Covid-19 to the lungs’ smallest blood vessels has been intricately captured ...

November 05, 2021

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

Feature | Radiology Business | Melinda Taschetta-Millane

November 2, 2021 — Here is a list of the Top 10 most popular pieces of content on ITNonline.com from the month of ...

November 02, 2021

Philips will demonstrate its Multimodality RT Simulation Workspace, a precision medicine application that provides a vendor-agnostic single space for simulation, multimodality image fusion and contouring

News | ASTRO

Philips Highlights New Patient-centered Innovations at ASTRO 2021

November 2, 2021 — Philips announced new innovations that can help improve cancer care across the patient journey at the ...

November 02, 2021

18F-FDG PET in patients with long-COVID syndrome. A and B: Transaxial sections of group averaged, spatially normalized 18F-FDG PET scans in patients with long-COVID syndrome (A) and control patients (B). C: The pattern expression score (PES; *adjusted for age and sex, for illustration purposes) of the previously established COVID-19-related spatial covariance pattern was not significantly different between patients with long-COVID syndrome and control patients. Boxplots (grey), as well as individual values

News | Coronavirus (COVID-19)

Molecular Imaging Suggests Long-COVID Symptoms may be Caused by Fatigue

November 1, 2021 — Long-term cognitive problems after a COVID-19 diagnosis may be a result of fatigue rather than ...

November 01, 2021

Chest radiograph without Auto Lung Nodule Detection (ALND) and chest radiograph with lung nodule marked.

News | Artificial Intelligence

Samsung Receives FDA Clearance for AI Algorithms that Detect Lung Nodules in Chest X-rays

October 28, 2021 — NeuroLogica Corp. announced it has received Food and Drug Administration (FDA) 510(k) clearance for ...

October 28, 2021

High-dose radiation therapy can be used to lengthen progression-free survival for people with advanced lung cancer when systemic therapy has not fully halted the growth or spread of metastases, according to a new study.

News | Stereotactic Body Radiation Therapy (SBRT)

High-dose Radiation Thwarts Tumor Growth in Patients with Advanced Lung Cancer

October 24, 2021 — High-dose radiation therapy can be used to lengthen progression-free survival for people with ...

October 24, 2021

Videos | Coronavirus (COVID-19)

VIDEO: Example of COVID Thrombosis on Ultrasound Imaging

An example of popliteal artery thrombosis formation caused by COVID-19 (SARS-CoV-2). Coronavirus often caused thrombus ...

October 19, 2021

(A) Pre-procedure axial image from contrast-enhanced CT scan of chest demonstrates a 1 cm solid right upper lobe nodule adjacent to right mainstem bronchus (arrow). (B) Intra-procedural coronal reformatted image shows two cryoablation probes within nodule. (C) 1-month follow-up sagittal chest CT image shows expected post-ablation changes encompassing treated nodule (arrow). (D) 1-year follow-up sagittal chest CT image shows expected involution of treatment zone into flat bandlike scar without residual tumor

News | Lung Imaging

Percutaneous Image-Guided Microwave and Cryoablation for Lung Sarcoma

October 11, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), percutaneous image-guided microwave and ...

October 11, 2021

Volpara Health, a global health technology software leader providing an integrated platform for the delivery of personalized breast and lung care, further expanded its footprint in the US lung screening market with a strategic relationship with Seattle-based lung AI company RevealDx.

News | Lung Imaging

Volpara Health Expands Lung Screening Capabilities Via Strategic Relationship with RevealDx

September 27, 2021 — Volpara Health, a global health technology software leader providing an integrated platform for the ...

September 27, 2021

The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center, Medical University of South Carolina Hollings Cancer Center and City of Hope Comprehensive Cancer Center secured a highly competitive Specialized Program of Research Excellence (SPORE) grant that aims to address lung cancer racial disparities through precision medicine, targeted smoking cessation programs and community outreach.

News | Lung Imaging

$3M Grant Establishes Center to Combat Racial Inequities in Lung Cancer

September 23, 2021 — The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center ...

September 23, 2021

Revised guidelines for lung cancer screening eligibility are perpetuating disparities for racial/ethnic minorities, according to a new study in Radiology.

News | Lung Imaging

Racial/Ethnic Disparities Persist in Lung Cancer Screening Eligibility

September 15, 2021 — Revised guidelines for lung cancer screening eligibility are perpetuating disparities for racial ...

September 15, 2021

An artificial intelligence (AI) program can spot signs of lung cancer on computed tomography (CT) scans a year before they can be diagnosed with existing methods, according to research presented at the European Respiratory Society International Congress.

News | Artificial Intelligence

Artificial Intelligence Could Help Diagnose Lung Cancer a Year Earlier

September 8, 2021 — An artificial intelligence (AI) program can spot signs of lung cancer on computed tomography (CT) ...

September 08, 2021

Videos | Coronavirus (COVID-19)

VIDEO: Examples of COVID-19 CT Scan Analysis Software

Several radiology IT vendors at 2021 Healthcare Information Management Systems Society (HIMSS) conference demonstrated ...

August 31, 2021

#coronavirus #COVID19 #pandemic #RSNA21 will require all attendees and exhibitors to show proof of #vaccination and wear a #mask

News | RSNA

RSNA21 Will Require Proof of Vaccination, Masks

August 12, 2021 — RSNA 2021 will require proof of COVID-19 vaccination from all in-person attendees and exhibitors at ...

August 12, 2021